2007
Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
Rosenheck RA, Leslie DL, Sindelar JL, Miller EA, Tariot PN, Dagerman KS, Davis SM, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS. Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease. JAMA Psychiatry 2007, 64: 1259-1268. PMID: 17984395, DOI: 10.1001/archpsyc.64.11.1259.Peer-Reviewed Original ResearchConceptsCost-benefit analysisSecond-generation antipsychoticsGreatest net health benefitNet benefit analysisNet health benefitWholesale priceHealth Utilities Index Mark 3Economic perspectiveAlzheimer's diseaseBenefit approachHealth care costsTotal health costsHealth costsQALYsCare costsMeasures of effectivenessPlacebo-controlled trialLower health care costsHealth service useTotal health careMeasures of functionCostTreatment of psychosisQuality of lifeSensitivity analysis
2006
Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J. Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia. American Journal Of Psychiatry 2006, 163: 2080-2089. PMID: 17151158, DOI: 10.1176/ajp.2006.163.12.2080.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntipsychotic AgentsChronic DiseaseCost-Benefit AnalysisDrug CostsFollow-Up StudiesHealth Care CostsHumansLongitudinal StudiesMiddle AgedPatient DropoutsPerphenazinePsychiatric Status Rating ScalesQuality-Adjusted Life YearsResearch DesignSchizophreniaSchizophrenic PsychologyTreatment Outcome
2003
Cost-effectiveness of Supported Housing for Homeless Persons With Mental Illness
Rosenheck R, Kasprow W, Frisman L, Liu-Mares W. Cost-effectiveness of Supported Housing for Homeless Persons With Mental Illness. JAMA Psychiatry 2003, 60: 940-951. PMID: 12963676, DOI: 10.1001/archpsyc.60.9.940.Peer-Reviewed Original ResearchMeSH KeywordsAdultCase ManagementCommunity-Institutional RelationsCost of IllnessCost-Benefit AnalysisFemaleFinancing, GovernmentGovernment AgenciesHealth Care CostsHealth StatusHumansIll-Housed PersonsMaleMental DisordersProgram EvaluationProspective StudiesPublic HousingSocial AdjustmentSubstance-Related DisordersUnited StatesUnited States Department of Veterans AffairsVeteransConceptsStandard care groupIntensive case managementStandard careCase managementCare groupMore daysMental illnessVeterans AffairsIncremental cost-effectiveness ratioSuperior housing outcomesSubstance abuse statusHUD-VASHMental health statusSubstance abuse disordersCost-effectiveness ratioCommunity adjustmentMental illness resultsSupported housing programsSecondary outcomesPrimary outcomeAbuse disordersIllness resultsControl groupHealth statusSocietal perspective
2001
Buprenorphine for opiate addiction: potential economic impact
Rosenheck R, Kosten T. Buprenorphine for opiate addiction: potential economic impact. Drug And Alcohol Dependence 2001, 63: 253-262. PMID: 11418229, DOI: 10.1016/s0376-8716(00)00214-3.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineCost-Benefit AnalysisCounselingDrug Evaluation, PreclinicalHealth Care CostsHumansMethadoneOpioid-Related DisordersConceptsBuprenorphine/naloxoneBuprenorphine/naloxone therapyBuprenorphine/naloxone combinationOffice-based treatmentHigh-cost patientsNet cost savingsNaloxone therapyToxicology screenMethadone clinicsNaloxone combinationNursing costsTreatment opportunitiesMultiple detoxificationsOpiate addictionNaloxoneOffice practicePatientsComparable groupsAdverse effectsMethadoneTreatmentAddictsNet savingsAddictionThe Effect of Institutional Fiscal Stress on the Use of Atypical Antipsychotic Medications in the Treatment of Schizophrenia
LESLIE D, ROSENHECK R. The Effect of Institutional Fiscal Stress on the Use of Atypical Antipsychotic Medications in the Treatment of Schizophrenia. The Journal Of Nervous And Mental Disease 2001, 189: 377-383. PMID: 11434638, DOI: 10.1097/00005053-200106000-00005.Peer-Reviewed Original ResearchMeSH KeywordsAlzheimer DiseaseAntipsychotic AgentsBenzodiazepinesBudgetsClozapineComorbidityDepressive DisorderDrug CostsFemaleHealth Care CostsHealth FacilitiesHumansMaleMiddle AgedOlanzapinePirenzepinePractice Patterns, Physicians'Regression AnalysisRisperidoneSchizophreniaTreatment OutcomeUnited StatesUnited States Department of Veterans AffairsConceptsAtypical antipsychotic medicationsTreatment of schizophreniaAtypical antipsychoticsAntipsychotic medicationExpensive atypical antipsychotic medicationsVeterans AffairsPrescription drug recordsGeneralized estimation equationsDrug recordsPatientsReduced likelihoodAntipsychoticsMedicationsFacility characteristicsSchizophreniaAtypicalsFinal sampleTreatmentOlanzapineRisperidone
2000
Benzodiazepine Use in Posttraumatic Stress Disorder among Veterans with Substance Abuse
KOSTEN T, FONTANA A, SERNYAK M, ROSENHECK R. Benzodiazepine Use in Posttraumatic Stress Disorder among Veterans with Substance Abuse. The Journal Of Nervous And Mental Disease 2000, 188: 454-459. PMID: 10919705, DOI: 10.1097/00005053-200007000-00010.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderHealth care utilizationSubstance abuseCare utilizationBenzodiazepine useOutpatient health care utilizationStress disorderComorbid substance abuseSubstance abuse diagnosisBenzodiazepine treatmentBaseline differencesInpatient dischargesBenzodiazepine usersAbuse diagnosisPTSD patientsAdverse effectsSubstance abusersBenzodiazepinesOutcomesVeteransDisordersAbusePatientsWorseningDiagnosisPreliminary Explorations of the Harmful Interactive Effects of Widowhood and Marital Harmony on Health, Health Service Use, and Health Care Costs1
Prigerson H, Maciejewski P, Rosenheck R. Preliminary Explorations of the Harmful Interactive Effects of Widowhood and Marital Harmony on Health, Health Service Use, and Health Care Costs1. The Gerontologist 2000, 40: 349-357. PMID: 10853529, DOI: 10.1093/geront/40.3.349.Peer-Reviewed Original ResearchOne‐year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: Evidence from a national database of health insurance claims
Striegel‐Moore R, Leslie D, Petrill S, Garvin V, Rosenheck R. One‐year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: Evidence from a national database of health insurance claims. International Journal Of Eating Disorders 2000, 27: 381-389. PMID: 10744844, DOI: 10.1002/(sici)1098-108x(200005)27:4<381::aid-eat2>3.0.co;2-u.Peer-Reviewed Original ResearchConceptsCosts of inpatientMale patientsFemale patientsOutpatient treatmentNational insurance databaseStandard of careHealth insurance claimsCost of treatmentTreatment guidelinesInsurance databaseOne-year useOutpatient servicesPatientsBulimia nervosaAnorexia nervosaUtilization dataNational databaseMore daysDisordersTreatmentInpatientsOne-year dataNervosaTerms of barriersInsurance claims
1999
Changing Patterns of Care for War-Related Post-Traumatic Stress Disorder at Department of Veterans Affairs Medical Centers: The Use of Performance Data to Guide Program Development
Rosenheck R, Fontana A. Changing Patterns of Care for War-Related Post-Traumatic Stress Disorder at Department of Veterans Affairs Medical Centers: The Use of Performance Data to Guide Program Development. Military Medicine 1999, 164: 795-802. PMID: 10578592, DOI: 10.1093/milmed/164.11.795.Peer-Reviewed Original ResearchConceptsPost-traumatic stress disorderVeterans Affairs Medical CenterInpatient programMedical CenterOutcome studiesStress disorderSpecialized inpatient programTreatment of PTSDPatterns of careSpecialized outpatient clinicEmphasis of careVA Medical CenterSpecialized outpatient treatmentWar-related post-traumatic stress disorderHealth care systemMost health care systemsInpatient outcomesOutpatient clinicOutpatient settingOutpatient treatmentOutpatient servicesOutcome assessmentMental illnessVA treatmentCare systemEffect of declining mental health service use on employees of a large corporation
Rosenheck R, Druss B, Stolar M, Leslie D, Sledge W. Effect of declining mental health service use on employees of a large corporation. Health Affairs 1999, 18: 193-203. PMID: 10495607, DOI: 10.1377/hlthaff.18.5.193.Peer-Reviewed Original ResearchShifting to Outpatient Care? Mental Health Care Use and Cost Under Private Insurance
Leslie D, Rosenheck R. Shifting to Outpatient Care? Mental Health Care Use and Cost Under Private Insurance. American Journal Of Psychiatry 1999, 156: 1250-1257. PMID: 10450268, DOI: 10.1176/ajp.156.8.1250.Peer-Reviewed Original ResearchConceptsMental health servicesMental health costsOutpatient careInpatient careTreatment daysService useHealth servicesMental health care useOutpatient mental health costsOutpatient service useInpatient service useProportion of enrolleesHealth care usePatterns of careHealth costsHealth care costsHospital daysIll patientsInpatient costsOutpatient claimsPrimary diagnosisCare useModerate depressionStudy groupOutpatient services